Oral delivery of poorly soluble compounds by supersaturated systems

Therapeutic Delivery

Volumn 2, Issue 6, 2011, Pages 685-690

  Lee, Thomas Wai Yip ^a   Boersen, Nathan A ^a   Hui, Ho Wah ^a   Kurtulik, Paul ^a  

^a CELGENE CORPORATION   (United States)

Author keywords

pharmaceutical salts; poorly soluble compounds; self emulsifying systems; solid dispersions; supersaturated delivery systems

Indexed keywords

ALPHA TOCOPHEROL; AMPRENAVIR; CREMOPHOR; CYCLOSPORIN A; DIACYLGLYCEROL; DRUG CARRIER; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; MONOACYLGLYCEROL; NAPROXEN; PACLITAXEL; POLYMER; RITONAVIR; SAQUINAVIR; SODIUM CHLORIDE; SURFACTANT; TRIACYLGLYCEROL; VEGETABLE OIL;

AREA UNDER THE CURVE; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG QUALITY; DRUG RESEARCH; DRUG SOLUBILITY; EMULSION; FOOD DRUG INTERACTION; GASTROINTESTINAL ABSORPTION; HUMAN; LIPOPHILICITY; MAXIMUM PLASMA CONCENTRATION; MELTING POINT; NONHUMAN; NOTE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SELF EMULSIFYING DRUG DELIVERY SYSTEM; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; SPRAY DRYING; SUPERSATURABLE SELF EMULSIFYING DRUG DELIVERY SYSTEM; THERMODYNAMICS; THERMOSTABILITY;

EID: 79960213371     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.49     Document Type: Note

References (32)

1. Lee A, Breitenbucher JG. The impact of combinatorial chemistry on drug discovery. Curr. Opin. Drug Discov. Dev. 6(4), 494-508 (2003) (Pubitemid 36975353)
2. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46(1-3), 3-26 (2001) (Pubitemid 33653411)
3. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification - the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12(3), 413-420 (1995)
4. Dressman J, Kramer J. Pharmaceutical Dissolution Testing. Taylor and Francis, NY, USA (2005)
5. Li SF, Wong SM, Sethia S et al. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm. Res. 22(4), 628-635 (2005) (Pubitemid 40603261)
6. Lee TWY, Li S, Bose S. Predictive pH gradient dissolution method for forecasting in vivo behavior of pharmaceutical weak acids and its salts. Presented at: American Association of Pharmaceutical Scientists. Baltimore, MA, USA 2004
7. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25(1), 103-128 (1997)
8. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60(6), 625-637 (2008)
9. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci. 11, S93-S98 (2000)
10. Bogman K, Erne-Brand F, Alsenz J, Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J. Pharm. Sci. 92(6), 1250-1261 (2003) (Pubitemid 36676470)
11. Hugger ED, Novak BL, Burton PS, Audus KL, Borchardt RT. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 91(9), 1991-2002 (2002) (Pubitemid 36254935)
12. Shono Y, Nishihara H, Matsuda Y et al. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J. Pharm. Sci. 93(4), 877-885 (2004)
13. Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin. Drug Deliv. 3(1), 97-110 (2006) (Pubitemid 43056394)
14. Pellett MA, Castellano S, Hadgraft J, Davis AF. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Release 46(3), 205-214 (1997) (Pubitemid 27132844)
15. Pellett MA, Davis AF, Hadgraft J. Effect of supersaturation on membrane-transport. 2. Poroxicam. Int. J. Pharm. 111(1), 1-6 (1994)
16. Pellett MA, Roberts MS, Hadgraft J. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int. J. Pharm. 151(1), 91-98 (1997) (Pubitemid 27212308)
17. Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int. J. Pharm. 193(2), 231-237 (2000) (Pubitemid 30001867)
18. Hasegawa A, Nakagawa H, Sugimoto I. Application of solid dispersion of Nifedipine with enteric coating agent to prepare a sustained-release dosage form. Chem. Pharm. Bull. 33(4), 1615-1619 (1985) (Pubitemid 15046091)
19. Kohri N, Yamayoshi Y, Xin H et al. Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J. Pharm. Pharmacol. 51(2), 159-164 (1999) (Pubitemid 29131308)
20. Hasegawa A, Taguchi M, Suzuki R et al. Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem. Pharm. Bull. 36(12), 4941-4950 (1988) (Pubitemid 19048290)
21. Ma XG, Taw J, Chiang CM. Control of drug crystallization in transdermal matrix system. Int. J. Pharm. 142(1), 115-119 (1996) (Pubitemid 26343836)
22. Raghavan SL, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int. J. Pharm. 212(2), 213-221 (2001) (Pubitemid 32119447)
23. Schwarb FP, Imanidis G, Smith EW, Haigh JM, Surber C. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm. Res. 16(6), 909-915 (1999) (Pubitemid 29284204)
24. Gao P, Rush BD, Pfund WP et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci. 92(12), 2386-2398 (2003) (Pubitemid 37484765)
25. Qiu Y, Chen Y, Zhang G, Liu L, Porter WR. Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice. Elsevier, Amsterdam, The Netherlands (2009)
26. Joshi HN, Tejwani RW, Davidovich M et al. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 269(1), 251-258 (2004) (Pubitemid 38032837)
27. Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin ATM. Development of clinical dosage forms for a poorly water soluble drug I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J. Pharm. Sci. 93(5), 1165-1175 (2004) (Pubitemid 38529690)
28. Hancock BC, Zograf G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86(1), 1-12 (1997)
29. Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low T-g drug: in vitro and in vivo evaluations. Pharm. Res. 22(6), 990-998 (2005) (Pubitemid 40898109)
30. Lakshman J, Cao Y, Kowalski J, Serajuddin ATM. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol. Pharm. 5(6), 994-1002 (2008)
31. Lakshman JP, Kowalski J, Vasanthavada M, et al. Application of melt granulation technology to enhance tabletting properties of poorly compactible high-dose drugs. J. Pharm. Sci. 100(4), 1553-1565 (2010)
32. Novartis AG. WO122022 (2006)